Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawkes, C. J.
Right arrow Articles by Roep, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawkes, C. J.
Right arrow Articles by Roep, B. O.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 3 356-366, Copyright © 2000 by American Diabetes Association


ARTICLES

T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes

CJ Hawkes, NC Schloot, J Marks, SJ Willemen, JW Drijfhout, EK Mayer, MR Christie and BO Roep
Department of Medicine, Guy's, King's College and St Thomas' School of Medicine, London, UK.

Type 1 diabetes is the result of destruction of the insulin-secreting beta-cells of the pancreas by a process in which T-cells play a central role. A tyrosine phosphatase-like protein, IA-2, is a major target for autoantibodies and T-cells in the disease. In this study, we have further characterized the T-cell response to IA-2 by the generation and characterization of T-cell lines. T-cell lines responsive to IA-2 antigen were generated from 17 of 32 patients and 3 of 10 control subjects. Antigen specificity was confirmed in lines from six diabetic patients and one control individual by demonstration of responses to synthetic IA-2 peptides and epitope mapping. Five lines from diabetic patients responded to one of two peptides representing amino acids 831-850 and 841-860 of IA-2. The overlapping portion may therefore represent an immunodominant region of the molecule. The sixth patient-derived line responded to a peptide representing amino acids 751-770 of IA-2 presented by the DR 4 (DRB1*0401) allele that confers susceptibility to type 1 diabetes. Primary T-cell responses to peptides of the immunodominant region were detected in 9 of 19 (47%) type 1 diabetic patients and 16 of 22 (73%) nondiabetic siblings, consistent with this region having immunostimulatory properties. The study reports for the first time T-cell lines reactive to IA-2 from diabetic patients and defines an immunodominant region of the molecule.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Dotta, S. Censini, A. G. S. van Halteren, L. Marselli, M. Masini, S. Dionisi, F. Mosca, U. Boggi, A. O. Muda, S. D. Prato, et al.
Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients
PNAS, March 20, 2007; 104(12): 5115 - 5120.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Kim, D. G. Jeong, S. K. Jeong, T.-S. Yoon, and S. E. Ryu
Crystal Structure of the Major Diabetes Autoantigen Insulinoma-Associated Protein 2 Reveals Distinctive Immune Epitopes
Diabetes, January 1, 2007; 56(1): 41 - 48.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Lindley, C. M. Dayan, A. Bishop, B. O. Roep, M. Peakman, and T. I.M. Tree
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Diabetes, January 1, 2005; 54(1): 92 - 99.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. I.M. Tree, G. Duinkerken, S. Willemen, R. R.P. de Vries, and B. O. Roep
HLA-DQ-Regulated T-Cell Responses to Islet Cell Autoantigens Insulin and GAD65
Diabetes, July 1, 2004; 53(7): 1692 - 1699.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Dromey, S. M. Weenink, G. H. Peters, J. Endl, P. J. Tighe, I. Todd, and M. R. Christie
Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants
J. Immunol., April 1, 2004; 172(7): 4084 - 4090.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kelemen, P. A. Gottlieb, A. L. Putnam, H. W. Davidson, D. R. Wegmann, and J. C. Hutton
HLA-DQ8-Associated T Cell Responses to the Diabetes Autoantigen Phogrin (IA-2{beta}) in Human Prediabetes
J. Immunol., March 15, 2004; 172(6): 3955 - 3962.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
M A Kelly, M L Rayner, C H Mijovic, and A H Barnett
Molecular aspects of type 1 diabetes
Mol. Pathol., February 1, 2003; 56(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bearzatto, H. Naserke, S. Piquer, K. Koczwara, V. Lampasona, A. Williams, M. R. Christie, P. J. Bingley, A.-G. Ziegler, and E. Bonifacio
Two Distinctly HLA-Associated Contiguous Linear Epitopes Uniquely Expressed Within the Islet Antigen 2 Molecule Are Major Autoantibody Epitopes of the Diabetes-Specific Tyrosine Phosphatase-Like Protein Autoantigens
J. Immunol., April 15, 2002; 168(8): 4202 - 4208.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. G. von Herrath, T. Wolfe, U. Mohrle, B. Coon, and A. Hughes
Protection From Type 1 Diabetes in the Face of High Levels of Activated Autoaggressive Lymphocytes in a Viral Transgenic Mouse Model Crossed to the SV129 Strain
Diabetes, December 1, 2001; 50(12): 2700 - 2708.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Kelemen, D. R. Wegmann, and J. C. Hutton
T-Cell Epitope Analysis on the Autoantigen Phogrin (IA-2{beta}) in the Nonobese Diabetic Mouse
Diabetes, August 1, 2001; 50(8): 1729 - 1734.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Peakman, T. I. Tree, J. Endl, P. van Endert, M. A. Atkinson, and B. O. Roep
Characterization of Preparations of GAD65, Proinsulin, and the Islet Tyrosine Phosphatase IA-2 for Use in Detection of Autoreactive T-Cells in Type 1 Diabetes: Report of Phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell Assays in Type 1 Diabetes
Diabetes, August 1, 2001; 50(8): 1749 - 1754.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Diez, Y. Park, M. Zeller, D. Brown, D. Garza, C. Ricordi, J. Hutton, G. S. Eisenbarth, and A. Pugliese
Differential Splicing of the IA-2 mRNA in Pancreas and Lymphoid Organs as a Permissive Genetic Mechanism for Autoimmunity Against the IA-2 Type 1 Diabetes Autoantigen
Diabetes, April 1, 2001; 50(4): 895 - 900.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini
Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes
J. Immunol., December 15, 2000; 165(12): 6748 - 6755.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.